Arsenic is a naturally occurring
metalloid strongly associated with the incidence of
lung cancer. Understanding the mechanisms of
arsenic-induced
carcinogenesis favors the development of effective interventions to reduce the incidence and mortality of
lung cancer. In this study, we investigated the role of
activating transcription factor 3 (ATF3) in
arsenic-induced transformation of human bronchial epithelial cells. ATF3 was upregulated during chronic exposure to 0.25 μM
arsenic, and loss of ATF3 promoted
arsenic-induced transformation. Moreover,
arsenic-transformed ATF3 knockout (ATF3 KO-AsT) cells exhibited more aggressive characteristics, including acceleration in proliferation, resistance to
chemotherapy and increase in migratory capacity.
RNA-seq revealed that pathways involved in
inflammation, cell cycle, EMT and
oncogenesis were affected due to ATF3 deficiency during chronic
arsenic exposure. Further experiments confirmed the overproduction of
IL-6,
IL-8 and TNFα as well as enhanced phosphorylation of AKT and STAT3 in ATF3 KO-AsT cells. Our results demonstrate that ATF3 upregulated by chronic low-dose
arsenic exposure represses cell transformation and acquisition of malignant characteristics through inhibiting the production of proinflammatory
cytokines and activation of downstream
proteins AKT and STAT3, providing a new strategy for the prevention of
carcinogen-induced
lung cancer.